Digital therapies for public health systems

Clinically validated digital therapies from Germany – for public health systems

In Germany, doctors have prescribed assessed digital therapies since 2020, and statutory health insurance pays for them.

Where we are exploring a route for digital therapies Health systems outside Germany for which we are assessing the approval, care and financing of digital therapies. A marker stands for our assessment, not for an existing collaboration. Germany Exploring

What digital therapies are

Patients use them on a smartphone or in a browser, for example for depression, type 2 diabetes or to stop smoking.

These therapies are software medical devices, specifically patient apps, expressly approved and clinically validated for their therapy. They treat each patient individually and on their own, without a person having to step in.

This makes them a complement to telemonitoring, which mainly provides data for treatment by doctors and nurses. And unlike hybrid programmes that depend on personal coaching, they can reach very large numbers of patients without additional staff.

So far, they hardly reach any other country. DUX wants to change that.

Approach

Our approach

Why good therapies stay in Germany, and how one licence, one platform and one partner change that.

Indications

Indications

Eight indications that Germany treats today with digital therapies on prescription.

  • Type 2 diabetes
  • Obesity
  • Depression
  • Anxiety disorders (panic disorder, phobias)
  • Mild cognitive impairment and dementia
  • Smoking cessation
  • Chronic heart failure
  • Erectile dysfunction

About DUX

About DUX

Who is behind DUX, and how to reach us.

How a collaboration starts

  1. Conversation

    We listen. Which programmes and goals do you have, and who pays for care?

  2. Market and regulatory review

    We clarify approval, data protection, hosting and procurement in your country.

  3. Pilot

    One indication, one region, measurable goals that you set.

  4. Scale-up

    More indications and regions on the same platform.

Contact

Let's talk about your programmes

In the first conversation, we listen: what are your goals, and who pays for care? 30 minutes with Christoph Eberhardt, on Microsoft Teams.

Christoph Eberhardt

Managing Director, DUX Healthcare GmbH

Book a 30-minute introduction